EP1425035A1 - USE OF BIOLOGICALLY ACTIVE HIV-1 TAT, FRAGMENTS OR DERIVATIVES THEREOF, TO TARGET AND/OR TO ACTIVATE ANTIGEN-PRESENTING CELLS, AND/OR TO DELIVER CARGO MOLECULES FOR PREVENTIVE OR THERAPEUTIC VACCINATION AND/OR TO TREAT OTHER DISEASES